Staar Surgical inks 44-hospital distribution deal in India
Staar Surgical (NSDQ:STAA) said yesterday it inked a distribution agreement with India-based EyeQ Vision Private to distribute Staar Evo Visian ICL intraocular lenses as a treatment for refractive vision treatment.
The deal includes supplying the lenses to 44 hospitals in north and west India, with plans to increase the number to 70 hospitals, including south and west India, within the next 2 years.
“With expansion plans to grow from our 44 hospitals in North and West India to over 70 hospitals including South and West India within the next two years, we made the decision to partner with STAAR Surgical to offer the...
Source: Mass Device - September 16, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Distribution Optical/Ophthalmic STAAR Surgical Co Source Type: news
Laser Device Approved for Nearsightedness
WEDNESDAY, Sept. 14, 2016 -- The VisuMax Femtosecond Laser has been approved by the U.S. Food and Drug Administration to treat nearsightedness in candidates 22 and older.
Nearsightedness, medically called myopia, is present when a person can see... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 14, 2016 Category: Journals (General) Source Type: news
FDA Approves VisuMax Femtosecond Laser to Treat Myopia FDA Approves VisuMax Femtosecond Laser to Treat Myopia
The laser is used in small-incision lenticule extraction to reshape the cornea and reduce or eliminate nearsightedness.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 13, 2016 Category: Consumer Health News Tags: Ophthalmology News Alert Source Type: news
Avedro taps Visiogen founder Zadno for CEO | Personnel Moves Sept. 9 2016
Avedro taps Visiogen founder Zadno for CEO
Avedro said it named the founder, president of Abbott (NYSE:ABT) acquisition Visiogen, Reza Zadno, to be its new CEO.
Zadno replaces CFO/COO Brian Roberts, the former CFO at Insulet (NSDQ:PODD), who stepped in on an interim basis when David Muller bowed out shortly after Avedro closed a $32 million equity round in November 2015.
In September 2009, Abbott paid $400 million for Visiogen and its Synchrony accommodating intraocular lens for treating presbyopia in cataract patients. Zadno was also chairman at a pair of other eye care companies that were bought by larger companies: T...
Source: Mass Device - September 9, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Business/Financial News Avedro Inc. DJO Global EnteroMedics Inc. Personnel Moves Source Type: news
The 3 Forces: The Perfect Storm Making Medical Errors the 3rd Leading Cause of Death
I previously posted twice on the scientific review paper led by Hopkins' researcher Martin Makary, MD, that concluded medical errors are the nation's third leading cause of death.
The raw estimate of 251,000 deaths per year is mind-numbing. What is even more disturbing is that the morbidity and mortality seems to be intractable. The number is not heading south, despite the 100,000 Lives Campaign from the Institute for Healthcare Improvement. Medicine's initiative to just-say-no to over-performance of services, Choosing Wisely: Things Providers Should Question has also not turned the tide. The estimate is up from the se...
Source: Healthy Living - The Huffington Post - September 6, 2016 Category: Consumer Health News Source Type: news
'Internal astigmatism' doesn't compensate for changes in the eye over time
(Wolters Kluwer Health) For people with nearsightedness (myopia), the lens doesn't compensate for growth or other changes in the structure of the eye, according to a long-term follow-up study in the September issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 29, 2016 Category: Global & Universal Source Type: news
Effectiveness Study of Atropine for Progressive Myopia Effectiveness Study of Atropine for Progressive Myopia
Atropine has shown to be an effective treatment option for progressive myopia among Asians, but does this same efficacy extend to patients of European descent? < br / > < i > Eye < /i > (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 26, 2016 Category: Consumer Health News Tags: Ophthalmology Journal Article Source Type: news
July Issue of NIH News in Health Now Available
The July issue of NIH News in Health is now available.
Featured stories include "Safeguarding Our Health: Vaccines Protect Us All" and "A Blurry Worldview: Understanding Myopia". Also, check out the health capsules and the featured Web site. (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - July 12, 2016 Category: Consumer Health News Source Type: news
Public Workshop â Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices, September 30, 2016
The Food and Drug Administration (FDA), American Academy of Ophthalmology (AAO), American Academy of Optometry (AAOpt), American Association for Pediatric Ophthalmology and Strabismus (AAPOS), American Optometric Association (AOA), American Society of... (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - July 11, 2016 Category: Medical Equipment Source Type: news
Federal Register: Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices; Public Workshop
The FDA, in cosponsorship with the American Academy of Ophthalmology (AAO), American Academy of Optometry (AAOpt), American Association for Pediatric Ophthalmology and Strabismus (AAPOS), American Optometric Association (AOA), American Society of Catar... (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - July 11, 2016 Category: Medical Equipment Source Type: news
July Issue of NIH News in Health Now Available
The July issue of NIH News in Health is now available.
Featured stories include "Safeguarding Our Health: Vaccines Protect Us All" and "A Blurry Worldview: Understanding Myopia". Also, check out the health capsules and the featured Web site. (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - July 7, 2016 Category: Consumer Health News Source Type: news
July 2016
Safeguarding Our Health: Vaccines Protect Us All...A Blurry Worldview: Understanding Myopia...Physical Activity Linked to Reduced Cancer Risk...Understanding Aphasia...Featured Web Site: Test Your Sense of Pitch (Source: NIH News in Health)
Source: NIH News in Health - July 1, 2016 Category: Consumer Health News Source Type: news
An exemplum and its road safety morals - Hauer E.
With the design of an existing bike-lane in mind I discuss several general issues: accident causation and its linkage to the formulation of prevention strategies; the myopia afflicting major studies of causation and their misleading 'the-driver-did-it' mes... (Source: SafetyLit)
Source: SafetyLit - June 26, 2016 Category: Global & Universal Tags: Commentary Source Type: news
Eye Strain Caused by Digital Screens
I’ve noticed a frightening trend occurring around the world. Instances of eye problems are increasing with rapid numbers.
Problems like myopia – once thought to be genetic – are going up exponentially with each passing year.
Many eye diseases have no early symptoms. You may not see a change in your vision until the disease has become advanced.
Are Eye Problems Genetic?
We have to look at the bigger picture here… eye problems aren’t always genetic, and there are changes in our environment that are having a negative impact on our eyesight.
Serious Eye Problems That Affects Your Vision
One area of concern is eye str...
Source: Al Sears, MD Natural Remedies - June 24, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news
Is Elon Musk Being Shortsighted, Or Should EV and Hydrogen Thrive Together?
Elon Musk is, without a doubt, one of the most forward thinking and entrepreneurial minds that has prominently emerged in the last few decades. His contributions to society, and particularly to science and the future of this Earth's sustainability, are nearly unparalleled among modern business professionals.
Musk is fond of stating that hydrogen is and will always be the future of transportation. Recently, Musk's co-founding partner at Tesla, Marc Tarpenning, added his thoughts alongside Musk, referring to hydrogen fuel technology in a less than positive manner. Musk, Tarpenning, and others share this feedback as they vie...
Source: Science - The Huffington Post - June 22, 2016 Category: Science Source Type: news
